It’s been two years since Alnylam’s founding CEO John Maraganore announced he was stepping back from the company. And in that time, he’s built up a bit of a persona for himself as biotech’s elder statesman. Multiple venture capital firms have enlisted his help in starting new companies and many founders aspire for him to join their boards.
And now Maraganore has a new venture, one that he hopes can expand on where he left off with Alnylam. Maraganore spoke with Readout LOUD hosts Allison DeAngelis and Adam Feuerstein about his new company and his impressions of the biotech industry today.
The interview has been lightly edited for length and clarity.
This article is exclusive to STAT+ subscribers
Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts.
Already have an account? Log in